Patent · US Active

Compounds for the treatment of neurodegenerative diseases

US8865754B2 · kind B2 · utility

1Cited by
21References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 1, 2012
Grant dateOct 21, 2014
Priority date
Expiry dateMar 1, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.